Summary Safety Review - KEPPRA (levetiracetam) - Assessing the Potential Risk of Acute Kidney Injury (Acute renal failure/Interstitial nephritis)

Health Canada reviewed the potential risk of acute kidney injury with the use of levetiracetam, because of an article that was published by the WHO suggesting this risk. Health Canada assessed the risk of acute kidney injury, which is defined as a sudden loss of kidney function, including kidney failure and interstitial nephritis. Interstitial nephritis is the inflammation of the kidneys and is one of the conditions that may lead to kidney failure.

Data and Resources

Additional Info

Field	Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French)	Résumé de l'examen de l'innocuité - KEPPRA (lévétiracétam) - Évaluation du risque potentiel de lésions rénales aiguës (insuffisance rénale aiguë/néphrite interstitielle)
Update Frequency	as_needed
Geographic Scope	[]
Criticality Level	[]
Sensitivity Level	unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published	2017-05-18 00:00:00
Open Canada Date Modified
Open Canada Subject	["health_and_safety"]
Open Canada Keywords	{"fr": ["Résumé de l'examen de l'innocuité", "KEPPRA", "lévétiracétam", "évaluation", "risque potentiel", "lésion rénale aiguë", "insuffisance rénale aiguë", "néphrite interstitielle"], "en": ["Summary Safety Review", "KEPPRA", "levetiracetam", "assessing", "potential risk", "Acute Kidney Injury", "Acute renal failure", "Interstitial nephritis"]}
Open Canada Collection	publication
Principal Organization
Reference Data
Official Source